HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 290/4/L710    most recent 00486.2004v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (17) Citing Articles via Google Scholar Google Scholar Articles by Helms, M. N. Articles by Jain, L. Search for Related Content PubMed PubMed Citation Articles by Helms, M. N. Articles by Jain, L.

Dopamine regulation of amiloride-sensitive sodium channels in lung cells

Departments of ¹Pediatrics and ²Physiology, and ³The Center for Cell and Molecular Signaling, Emory University School of Medicine, Atlanta, Georgia

Submitted 30 December 2004 ; accepted in final form 3 November 2005

Dopamine increases lung fluid clearance. This is partly due to activation of basolateral Na-K-ATPase. However, activation of Na-K-ATPase by itself is unlikely to produce large changes in transepithelial transport. Therefore, we examined apical and basolateral dopamine's effect on apical, highly selective sodium channels [epithelial sodium channels (ENaC)] in monolayers of an alveolar type 2 cell line (L2). Dopamine increased channel open probability (P_o) without changing the unitary current. The D₁ receptor blocker SCH-23390 blocked the dopamine effect, but the D₂ receptor blocker sulpiride did not. The dopamine-mediated increase in ENaC activity was not a secondary effect of dopamine stimulation of Na-K-ATPase, since ouabain applied to the basolateral surface to block the activity of Na-K-ATPase did not alter dopamine-mediated ENaC activity. Protein kinase A (PKA) was not responsible for dopamine's effect since a PKA inhibitor, H89, did not reduce dopamine's effect. However, cpt-2-O-Me-cAMP, which selectively binds and activates EPAC (exchange protein activated by cAMP) but not PKA, increased ENaC P_o. An Src inhibitor, PP2, and the phosphatidylinositol-3-kinase inhibitor, LY-294002, blocked dopamine's effect on ENaC. In addition, an MEK blocker, U0126, an inhibitor of phospholipase A₂, and a protein phosphatase inhibitor also blocked the effect of dopamine on ENaC P_o. Finally, since the cAMP-EPAC-Rap1 pathway also activates DARPP32 (32-kDa dopamine response protein phosphatase), we confirmed that dopamine phosphorylates DARPP32, and okadaic acid, which blocks phosphatases (DARPP32), also blocks dopamine's effect. In summary, dopamine increases ENaC activity by a cAMP-mediated alternative signaling pathway involving EPAC and Rap1, signaling molecules usually associated with growth-factor-activated receptors.

single channel recording; ion transport; epithelial sodium channels; L2 lung cells; exchange protein activated by cAMP

This article has been cited by other articles:

				L. Yu, M. N. Helms, Q. Yue, and D. C. Eaton Single-channel analysis of functional epithelial sodium channel (ENaC) stability at the apical membrane of A6 distal kidney cells Am J Physiol Renal Physiol, November 1, 2008; 295(5): F1519 - F1527. [Abstract] [Full Text] [PDF]

				H. F. Bao, L. Liu, J. Self, B. J. Duke, R. Ueno, and D. C. Eaton A synthetic prostone activates apical chloride channels in A6 epithelial cells Am J Physiol Gastrointest Liver Physiol, August 1, 2008; 295(2): G234 - G251. [Abstract] [Full Text] [PDF]

				Y. Li, I. B. M. Konings, J. Zhao, L. S. Price, E. de Heer, and P. M. T. Deen Renal expression of exchange protein directly activated by cAMP (Epac) 1 and 2 Am J Physiol Renal Physiol, August 1, 2008; 295(2): F525 - F533. [Abstract] [Full Text] [PDF]

				G. Kang, C. A. Leech, O. G. Chepurny, W. A. Coetzee, and G. G. Holz Role of the cAMP sensor Epac as a determinant of KATP channel ATP sensitivity in human pancreatic {beta}-cells and rat INS-1 cells J. Physiol., March 1, 2008; 586(5): 1307 - 1319. [Abstract] [Full Text] [PDF]

				S. M. Kaestle, C. A. Reich, N. Yin, H. Habazettl, J. Weimann, and W. M. Kuebler Nitric oxide-dependent inhibition of alveolar fluid clearance in hydrostatic lung edema Am J Physiol Lung Cell Mol Physiol, October 1, 2007; 293(4): L859 - L869. [Abstract] [Full Text] [PDF]

				J. L. Holzman, L. Liu, B. J. Duke, A. E. Kemendy, and D. C. Eaton Transactivation of the IGF-1R by aldosterone Am J Physiol Renal Physiol, April 1, 2007; 292(4): F1219 - F1228. [Abstract] [Full Text] [PDF]

				G. G. Holz, G. Kang, M. Harbeck, M. W. Roe, and O. G. Chepurny Cell physiology of cAMP sensor Epac J. Physiol., November 15, 2006; 577(1): 5 - 15. [Abstract] [Full Text] [PDF]

				M. N. Helms, J. Self, H. F. Bao, L. C. Job, L. Jain, and D. C. Eaton Dopamine activates amiloride-sensitive sodium channels in alveolar type I cells in lung slice preparations Am J Physiol Lung Cell Mol Physiol, October 1, 2006; 291(4): L610 - L618. [Abstract] [Full Text] [PDF]

				D. M. Guidot, H. G. Folkesson, L. Jain, J. I. Sznajder, J.-F. Pittet, and M. A. Matthay Integrating acute lung injury and regulation of alveolar fluid clearance Am J Physiol Lung Cell Mol Physiol, September 1, 2006; 291(3): L301 - L306. [Abstract] [Full Text] [PDF]